Island Pharmaceuticals Ltd (ILA)

Currency in AUD
0.44
+0.02(+4.71%)
Closed·
ILA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.430.44
52 wk Range
0.210.63
Key Statistics
Bid/Ask
0.46 / 0.44
Prev. Close
0.43
Open
0.43
Day's Range
0.43-0.44
52 wk Range
0.21-0.63
Volume
174.57K
Average Volume (3m)
271.9K
1-Year Change
120%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ILA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Earnings

Latest Release
Aug 26, 2026
EPS / Forecast
-0.02 / -1.20
Revenue / Forecast
241.87K / --
EPS Revisions
Last 90 days

ILA Income Statement

Compare ILA to Peers and Sector

Metrics to compare
ILA
Peers
Sector
Relationship
P/E Ratio
−13.2x−7.2x−0.4x
PEG Ratio
0.22−0.120.00
Price/Book
9.7x4.2x2.6x
Price / LTM Sales
460.6x10.8x3.1x
Upside (Analyst Target)
263.6%104.7%49.0%
Fair Value Upside
Unlock17.5%7.0%Unlock

Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States. The company’s lead product candidate is ISLA-101, a drug which is in second clinical-stage for the prevention and treatment of dengue fever and other mosquito vector borne diseases; and Galidesivir, a spectrum antiviral candidate with the potential to address multiple high-priority RNA virus threats. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
39.70M13.42%17.47M
Public Companies & Retail Investors
256.21M86.58%112.73M
Total
295.92M100.00%130.2M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Mwp Partners Limited6.51%19,264,7738,477
KESA Partners, Inc.3.75%11,104,0344,886

FAQ

What Is the Island Pharmaceuticals (ILA) Stock Price Today?

The Island Pharmaceuticals stock price today is 0.44 AUD.

What Stock Exchange Does Island Pharmaceuticals Trade On?

Island Pharmaceuticals is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Island Pharmaceuticals?

The stock symbol for Island Pharmaceuticals is "ILA."

What Is the Island Pharmaceuticals Market Cap?

As of today, Island Pharmaceuticals market cap is 125.76M AUD.

What Is Island Pharmaceuticals's Earnings Per Share (TTM)?

The Island Pharmaceuticals EPS (TTM) is -0.04.

When Is the Next Island Pharmaceuticals Earnings Date?

Island Pharmaceuticals will release its next earnings report on Aug 26, 2026.

From a Technical Analysis Perspective, Is ILA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Island Pharmaceuticals Stock Split?

Island Pharmaceuticals has split 0 times.

What is the current trading status of Island Pharmaceuticals (ILA)?

As of Sep 02, 2026, Island Pharmaceuticals (ILA) is trading at a price of 0.44 AUD, with a previous close of 0.43 AUD. The stock has fluctuated within a day range of 0.43 AUD to 0.44 AUD, while its 52-week range spans from 0.21 AUD to 0.63 AUD.

What Is Island Pharmaceuticals (ILA) Price Target According to Analysts?

The average 12-month price target for Island Pharmaceuticals is 1.60 AUD, with a high estimate of 1.6 AUD and a low estimate of 1.6 AUD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +263.64% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.